References
1. Allarakia S, Khayat HA, Karami MM, et al. Characteristics and management of mirror syndrome: a systematic review (1956-2016). J Perinat Med . 2017;45(9):1013-1021.
2. Lawenda BD, Mondry TE, Johnstone PA. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. Ca-Cancer J Clin . 2009;59(1):8-24.
3. Czernik C, Proquitté H, Metze B, Bührer C. Hydrops fetalis–has there been a change in diagnostic spectrum and mortality? J Matern-Fetal Neonat Med . 2011;24(2):258-263.
4. Porat S, Fitzgerald B, Wright E, Keating S, Kingdom JC. Placental hyperinflation and the risk of adverse perinatal outcome.Ultrasound Obstet Gynecol . 2013;42(3):315-321.
5. Braun T, Brauer M, Fuchs I, et al. Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome. Fetal Diagn Ther . 2010;27(4):191-203.
6. Takci S, Gharibzadeh M, Yurdakok M, et al. Etiology and outcome of hydrops fetalis: report of 62 cases. Pediatr Neonatol . 2014;55(2):108-113.
7. McEwan A. Fetal anaemia. Obstet Gynaecol Reprod Med . 2019;29(8):233-239.
8. Gaetani M, Damiani gr, Pellegrino A, et al. Diagnosis and management of a rare case of fetal mediastinal teratoma without non-immunological hydrops. J Obstet Gynaecol . 2015;36:1-3.
9. Moise KJ, Jr. Management of rhesus alloimmunization in pregnancy.Obstet Gynecol . 2008;112(1):164-176.
10. Sohan K, Carroll SG, De La Fuente S, Soothill P, Kyle P. Analysis of outcome in hydrops fetalis in relation to gestational age at diagnosis, cause and treatment. Acta Obstet Gynecol Scand . 2001;80(8):726-730.
11. Hobson SR, Wallace EM, Chan YF, Edwards AG, Teoh MWT, Khaw AP. Mirroring preeclampsia: the molecular basis of Ballantyne syndrome.J Matern-Fetal Neonat Med . 2020;33(5):768-773.
12. ACOG practice bulletin no. 192: management of alloimmunization during pregnancy. Obstet Gynecol . 2018;131(3):e82-e90.
13. Krishnan V, Shenoy V, Sunny S, et al. Defining critical antibody titre in column agglutination method to guide fetal surveillance.Transfus Apher Sci . 2020;59(3):102732.
14. Martinez-Portilla RJ, Lopez-Felix J, Hawkins-Villareal A, et al. Performance of fetal middle cerebral artery peak systolic velocity for prediction of anemia in untransfused and transfused fetuses: systematic review and meta-analysis. https://doi.org/10.1002/uog.20273.Ultrasound Obstet Gynecol . 2019;54(6):722-731.
15. Deleers M, Guizani M, Jani J, Hulot M, El Kenz H. A case of severe foetal anaemia due to anti-Kell that could not be detected by the weekly assessment of middle cerebral artery peak systolic velocity.Transfus Apher Sci . 2018;57(1):111-113.
16. Arslan E, Demir SC, Ozsurmeli M, Akcabay C. Perinatal outcomes and survival predictors of severe red-cell alloimmunization treated by intrauterine transfusion. J Obstet Gynaecol . 2021;47(8):2632-2640.
Smoleniec J, Anderson N, Poole G. Hydrops fetalis caused by a blood group antibody usually undetected in routine screening. Archives of disease in childhood Fetal and neonatal edition. 1994;71(3):F216-217.
18. Koshy R, Patel B, Harrison JS. Anti-Kpa-induced severe delayed hemolytic transfusion reaction. Immunohematology. 2009;25(2):44-47
19. Le Vaillant C, Jacopin-Bruneau L, Nowak C, Riteau AS. Two cases of unusual allo-immunization caused by atypical antibodies. Presse medicale (Paris, France : 1983).2015;44(10):1078-1082.Allo-immunisation materno-fœtale par anticorps atypiques à propos de deux cas cliniques.
20. Brumbaugh JE, Morgan S, Beck JC, et al. Blueberry muffin rash, hyperbilirubinemia, and hypoglycemia: a case of hemolytic disease of the fetus and newborn due to anti-Kp(a). Journal of perinatology : official journal of the California Perinatal Association. 2011;31(5):373-376.
21. Geczy A, Ennis J, Golian PR. A further example of anti-kpa. Transfusion. 1965;5:89-91.
22. Costamagna L, Barbarini M, Viarengo GL, Pagani A, Isernia D, Salvaneschi L. A case of hemolytic disease of the newborn due to anti-Kpa. Immunohematology. 1997;13(2):61-62.
23. Tuson M, Hue-Roye K, Koval K, et al. Possible suppression of fetal erythropoiesis by the Kell blood group antibody anti-Kp(a). Immunohematology. 2011;27(2):58-60.